ENTITY
Telix Pharmaceuticals

Telix Pharmaceuticals (TLX AU)

88
Analysis
Health CareAustralia
Telix Pharmaceuticals Limited operates as a biotechnology company. The Company develops and commercializes molecularly-targeted radiation therapy for the treatment of prostate, renal, and brain cancer. Telix Pharmaceuticals serves patients worldwide.
more
bullishDroneShield Ltd
03 Jul 2025 14:01Syndicated

Rudi's View: Charter Hall, Droneshield, Pinnacle, WiseTech & More

Update on changes to and revisions of analysts' Best Ideas and Conviction Calls, as well as Model Portfolio compositions

Logo
FNArena
270 Views
Share
bullishLife360 Inc
27 Jun 2025 00:00Syndicated

Rudi's View: CBA, Life360, ResMed, Zip & More

Update on changes to and revisions of analysts' Best Ideas and Conviction Calls, as well as Model Portfolio compositions

Logo
FNArena
267 Views
Share
05 Nov 2020 15:38Issuer-paid

Telix Pharmaceuticals - Telix signs a big China deal

Telix announced on 2 November 2020 that it has entered into a licensing agreement with China Grand Pharmaceutical (CGP) for the greater Chinese...

Share
28 Sep 2020 21:20Issuer-paid

Telix Pharmaceuticals - TLX591-CDx NDA submitted

On 24 September 2020 Telix announced it had submitted its NDA to the FDA for approval of TLX591-CDx, its positron emission tomography (PET) imaging...

Share
08 Sep 2020 20:54Issuer-paid

Telix Pharmaceuticals - A look at future directions

For the first time, Telix provided a profile of its deep pipeline outside its lead asset on its H120 earnings call. It presented the details of...

Share
x